The Latest Breaking News from FDA

The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation

January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…

Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. Even if approved, the medication may not reach many people who need it.

‘You cannot underestimate how difficult it has been’ for civil servants who filed complaints against the Deputy PM, Dave Penman said.

Travere Therapeutics said on Friday the U.S. health regulator has granted accelerated approval to its drug to treat a type of chronic kidney disease, IgAN, in adults with a high risk of advancing to kidney failure.

On May 11, the central pillar of the country's pandemic response — the declaration of a national emergency that began March 1, 2020 — will come down. But Americans will continue to have access to the vaccines, drugs and medical devices that were authorized for emergency use against COVID-19, so…

As a sophomore in college in 2011, I was deferred from donating blood for being a gay man. I was confronting the homophobia built into the FDA’s blood donation ban for men who have sex with men.

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the bills.

The most popular abortion method in the U.S. could vanish from the market, leaving providers scrambling to find alternatives after the end of Roe v. Wade.